Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes
SAME
1 other identifier
interventional
436
1 country
1
Brief Summary
The study aims to develop and evaluate a new, multifaceted (complex) intervention in a mixed methods study-design to increase medication safety in nursing homes. The SAME-study will be locally anchored, including investigation of patient safety culture, in a mixed methods design, including both in depth qualitative and organizational-focused quantitative methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
August 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedMay 1, 2024
April 1, 2024
3.1 years
June 30, 2021
April 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Care staff's perceptions of patient safety culture
Safety Attitudes Questionnaire (SAQ)
One year
Secondary Outcomes (1)
Perceptions of patient safety culture of relatives of residents and nursing home doctors.
One year
Other Outcomes (1)
Safety assessments
One year
Study Arms (2)
Intervention
OTHERThe complex intervention will be co-developed during first phase of the study.
Control
NO INTERVENTIONHalf of the group will be included as control and thus not exposed to the intervention.
Interventions
Eligibility Criteria
You may qualify if:
- involved directly or indirectly in the medication process
- employment of at least two months in a nursing-home within the municipality of Aalborg, sufficient spoken and written Danish language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anne Estrup Olesenlead
- Aalborg Universitycollaborator
- Aalborg Municipalitycollaborator
- University College of Northern Denmarkcollaborator
Study Sites (1)
Aalborg University Hospital
Aalborg, 9000, Denmark
Related Publications (1)
Juhl MH, Soerensen AL, Kristensen JK, Johnsen SP, Olesen AE. Safe Medication in Nursing Home Residents Through the Development and Evaluation of an Intervention (SAME): Protocol for a Fully Integrated Mixed Methods Study With a Cocreative Approach. JMIR Res Protoc. 2023 Mar 31;12:e43538. doi: 10.2196/43538.
PMID: 37000508DERIVED
Study Officials
- STUDY DIRECTOR
Anne E Olesen, Ph.D.
Aalborg University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 30, 2021
First Posted
August 5, 2021
Study Start
October 1, 2020
Primary Completion
October 31, 2023
Study Completion
October 31, 2023
Last Updated
May 1, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- We plan to publish the protocol during fall 2021
We plan to publish the protocol